Literature DB >> 2909640

Penicillin-binding protein families: evidence for the clonal nature of penicillin resistance in clinical isolates of pneumococci.

D Jabes1, S Nachman, A Tomasz.   

Abstract

In view of the worldwide emergence of penicillin-resistant pneumococci among clinical isolates it was of importance to examine a large number of strains to test the uniformity of the resistance mechanism. Among 160 clinical isolates of pneumococci (minimum inhibitory concentration [MIC], 0.005-16 micrograms/mL), susceptible strains showed a common pattern of five penicillin-binding proteins (PBPs) with high penicillin affinities (PBP 3 greater than 1A greater than or equal to 2A greater than 1B greater than 2B). PBPs 1A, 2A, and 2B (but not PBP 3) each showed distinct stepwise decreases in penicillin affinities parallel with increasing levels of antibiotic resistance. The number and molecular sizes of PBPs became variable in strains with MIC values greater than 1.0 microgram/mL; among 39 strains with a MIC of greater than or equal to 1.0 microgram/mL, 11 distinct and stable PBP patterns could be identified. Using PBP profiles, serotypes, and antibiotic resistance patterns, as well as data on isolation dates and sites, we identified at least three groups of resistant strains that showed clear indication of clonal origin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2909640     DOI: 10.1093/infdis/159.1.16

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  27 in total

1.  Long-term shifts in patterns of antibiotic resistance in enteric bacteria.

Authors:  T Houndt; H Ochman
Journal:  Appl Environ Microbiol       Date:  2000-12       Impact factor: 4.792

2.  Clonal groups of penicillin-nonsusceptible Streptococcus pneumoniae in Baltimore, Maryland: a population-based, molecular epidemiologic study.

Authors:  M C McEllistrem; M Pass; J A Elliott; C G Whitney; L H Harrison
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network.

Authors:  L McGee; L McDougal; J Zhou; B G Spratt; F C Tenover; R George; R Hakenbeck; W Hryniewicz; J C Lefévre; A Tomasz; K P Klugman
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

Review 4.  Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions.

Authors:  S J Schrag; B Beall; S F Dowell
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

5.  Genetic relationships of penicillin-susceptible and -resistant Streptococcus pneumoniae strains isolated on different continents.

Authors:  C Sibold; J Wang; J Henrichsen; R Hakenbeck
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

6.  A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone.

Authors:  A M Figueiredo; J D Connor; A Severin; M V Vaz Pato; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

7.  Combinational detection of autolysin and penicillin-binding protein 2B genes of Streptococcus pneumoniae by PCR.

Authors:  K Ubukata; Y Asahi; A Yamane; M Konno
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

8.  Evidence of recombination and an antigenically diverse immunoglobulin A1 protease among strains of Streptococcus pneumoniae.

Authors:  H Lomholt
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

9.  Antibiotic resistance in common acute respiratory pathogens.

Authors:  P Venkatesan; J A Innes
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

10.  Determination of penicillin MICs for Streptococcus pneumoniae by using a two- or three-disk diffusion procedure.

Authors:  M R Jacobs; S Bajaksouzian; E L Palavecino-Fasola; H M Holoszyc; P C Appelbaum
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.